Fritz Oesterle, head of the south German drug wholesale group Celesio, has said that, despite the latest ruling of the European Court of Justice (Marketletters passim) the establishment of pharmacy chains in Germany in the medium to longer term is inevitable and unavoidable.
These chains, operated and managed as capital enterprises, would only be the continuation of a trend that started in the 1980s when pharmacists started to compete with each other using promotions. This fashion has now reached its logical next-phase with more and more flexible competition, he stated.
Earlier, the European Court ruled that the current German legal position on pharmacy ownership restrictions was in line with European law with an independent pharmacist only allowed to own and run a pharmacy. Private capital companies are excluded. The judgement came as a reverse for Celesio and for pharmacists who want to establish chains across the country.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze